US Stock MarketDetailed Quotes

TFFP TFF Pharmaceuticals

Watchlist

2.2100
+0.0400+1.84%

Close Sep 12 16:00 ET

7.66MMarket Cap-321P/E (TTM)

TFF Pharmaceuticals Stock Forum

Trytosaveabit

Sep 11 06:09

Update

$TFF Pharmaceuticals (TFFP.US)$ Benzinga· 3 mins ago
TFF Pharmaceuticals Announced Its New Partnership With Emory University And The Biomedical Advanced Research And Development Authority To Develop A Dry Powder Inhaled Mrna-based Treatment For Influenza And Covid

Jaguar8

Sep 10 06:57

NEWS

$TFF Pharmaceuticals (TFFP.US)$
TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization
TFF-dry powder HA antigen vaccine candidates induced neutralizing antibody titers in ferrets against H1 and H3 influenza strains
Ongoing funded work to assess additional influenza strains
FORT WORTH, Texas, Sept. 10, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (NASDAQ:TFFP) (the "Company" or "TF...

Trytosaveabit

Aug 6 07:04

Update

$TFF Pharmaceuticals (TFFP.US)$ Reuters· 3 mins ago
TFF Pharmaceuticals Provides Continued Positive Outcomes From Tacrolimus Inhalation Powder (TFF Tac) Phase 2 Trial for the Prevention of Lung Transplant Rejection

Trytosaveabit

Jun 24 06:07

FDA meeting went well!

$TFF Pharmaceuticals (TFFP.US)$ TFF Pharmaceuticals: Based on FDA Feedback, Does Not Expect Change to Timelines or Estimated Costs Associated With Clinical Advancement of TFF Tac

Trytosaveabit

May 20 06:07

Update

$TFF Pharmaceuticals (TFFP.US)$ Benzinga· 1 min ago
TFF Pharmaceuticals, Cleveland Clinic Partner To Advance Multiple Multivalent Universal Influenza Vaccines To Protect Against Seasonal, Pandemic Viruses Into Preclinical Testing

Jaguar8

May 15 06:41

$TFF Pharmaceuticals (TFFP.US)$
NEWS
TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection
TFF Pharmaceuticals announced an update on its Phase 2 trial of Tacrolimus Inhalation Powder (TFF TAC) for preventing lung transplant rejection. The trial has accelerated patient enrollment with 10 patients currently enrolled. All 6 patients who completed the 12-week treatment have opted to continue to the safety extension...

Trytosaveabit

May 14 15:45

Update

$TFF Pharmaceuticals (TFFP.US)$ TFF Pharmaceuticals Expects To Receive FDA Feedback In Q2 Regarding TFF TAC Clinical Development Plan And Next Steps

Trytosaveabit

May 1 16:15

Hmm? Believe goes back on watch! I likes the bottoms! Hehehe

$TFF Pharmaceuticals (TFFP.US)$ Just off ATL @2.51! OS on the daily! RSI 7 = 24.10 RSI 14 = 28.22! MACD Curling up, fixing to make that GC, if completes the trend? NFA Just thinking outloud!